연구성과로 돌아가기
JCR 2022 저널 목록 (922 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COMMUNICATIONS ON PURE AND APPLIED ANALYSIS | AMER INST MATHEMATICAL SCIENCES-AIMS | 1534-0392 | 1553-5258 | SCIE | MATHEMATICS, APPLIED | 2,152 | 1.0 | Q3 | 67.2 | 32.8 | 180/267 | 1.1 | Q3 | 0.9 | 0.3 | 0.82 | 121/327 | Q2 | 63.15 | 0.005 | 1.022 | 0.596 | Q3 | 170 | 100.0% | 6.5 | 12.5 | 170 | 99.0% | 2025-04-21 10:12:53 | 바로가기 |
| Cost Effectiveness and Resource Allocation | BMC | 1478-7547 | 1478-7547 | SSCI | HEALTH POLICY & SERVICES | 1,020 | 2.3 | Q3 | 67.2 | 32.8 | 59/87 | 2.4 | Q3 | 2.2 | 0.3 | 0.70 | 66/117 | Q3 | 44.02 | 0.001 | 0.294 | 0.669 | Q3 | 70 | 84.3% | 4.8 | 7.2 | 59 | 100.0% | 2025-04-21 10:00:48 | 바로가기 |
| CURRENT HISTORY | UNIV CALIFORNIA PRESS | 0011-3530 | 1944-785X | SSCI | INTERNATIONAL RELATIONS | 465 | 1.3 | Q3 | 67.2 | 32.8 | 65/96 | 0.9 | Q4 | 1.3 | 1.0 | 0.41 | 110/160 | Q3 | 31.56 | 0.001 | 0.169 | 0.504 | Q4 | 10 | 100.0% | 8.6 | N/A | 10 | 0.0% | 2025-04-21 10:06:01 | 바로가기 |
| DEMENTIA AND GERIATRIC COGNITIVE DISORDERS | KARGER | 1420-8008 | 1421-9824 | SCIE | CLINICAL NEUROLOGY | 5,165 | 2.4 | Q3 | 67.2 | 32.8 | 143/212 | 3.0 | Q3 | 2.4 | 0.2 | 0.58 | 176/269 | Q3 | 34.76 | 0.002 | 0.453 | 0.745 | Q3 | 55 | 92.7% | 12.5 | 8.5 | 51 | 21.2% | 2025-04-21 09:39:43 | 바로가기 |
| EMPLOYEE RELATIONS | EMERALD GROUP PUBLISHING LTD | 0142-5455 | 1758-7069 | SSCI | MANAGEMENT | 2,651 | 3.4 | Q3 | 67.2 | 32.8 | 153/227 | 3.4 | Q3 | 3.1 | 0.8 | 0.99 | 123/401 | Q2 | 69.45 | 0.002 | 0.450 | 0.577 | Q4 | 84 | 100.0% | 5.4 | 9.0 | 84 | 7.5% | 2025-04-21 10:10:24 | 바로가기 |
| ENGINEERING COMPUTATIONS | EMERALD GROUP PUBLISHING LTD | 0264-4401 | 1758-7077 | SCIE | ENGINEERING, MULTIDISCIPLINARY | 2,954 | 1.6 | Q3 | 67.2 | 32.8 | 61/90 | 1.5 | Q3 | 1.5 | 0.3 | 1.67 | 15/178 | Q1 | 91.85 | 0.002 | 0.454 | 0.282 | Q3 | 67 | 100.0% | 7.8 | 9.3 | 67 | 1.0% | 2025-04-21 09:54:32 | 바로가기 |
| Ethics & International Affairs | CAMBRIDGE UNIV PRESS | 0892-6794 | 1747-7093 | SSCI | INTERNATIONAL RELATIONS | 768 | 1.3 | Q3 | 67.2 | 32.8 | 65/96 | 1.9 | Q3 | 1.3 | 0.2 | 0.51 | 100/160 | Q3 | 37.81 | 0.001 | 0.205 | 0.799 | Q3 | 25 | 84.0% | 8.4 | 8.9 | 21 | 32.5% | 2025-04-21 10:05:59 | 바로가기 |
| EUROPEAN NEUROLOGY | KARGER | 0014-3022 | 1421-9913 | SCIE | CLINICAL NEUROLOGY | 3,841 | 2.4 | Q3 | 67.2 | 32.8 | 143/212 | 2.2 | Q4 | 2.3 | 0.6 | 0.46 | 207/269 | Q4 | 23.23 | 0.002 | 0.491 | 0.643 | Q3 | 51 | 70.6% | 11.9 | 7.7 | 36 | 13.8% | 2025-04-21 09:39:45 | 바로가기 |
| Expert Review of Pharmacoeconomics & Outcomes Research | TAYLOR & FRANCIS LTD | 1473-7167 | 1744-8379 | SSCI | HEALTH POLICY & SERVICES | 2,485 | 2.3 | Q3 | 67.2 | 32.8 | 59/87 | 2.4 | Q3 | 2.2 | 0.3 | 0.55 | 87/117 | Q3 | 26.07 | 0.003 | 0.557 | 0.645 | Q4 | 81 | 82.7% | 6.7 | 6.0 | 67 | 20.5% | 2025-04-21 10:00:45 | 바로가기 |
| EXTREMOPHILES | SPRINGER JAPAN KK | 1431-0651 | 1433-4909 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 3,478 | 2.9 | Q3 | 67.2 | 32.8 | 192/285 | 2.6 | Q4 | 2.7 | 1.0 | 0.52 | 217/315 | Q3 | 31.27 | 0.002 | 0.339 | 0.495 | Q3 | 37 | 89.2% | 9.8 | 9.4 | 33 | 17.8% | 2025-04-21 09:33:45 | 바로가기 |
| FINITE FIELDS AND THEIR APPLICATIONS | ACADEMIC PRESS INC ELSEVIER SCIENCE | 1071-5797 | 1090-2465 | SCIE | MATHEMATICS, APPLIED | 1,638 | 1.0 | Q3 | 67.2 | 32.8 | 180/267 | 1.2 | Q3 | 0.8 | 0.2 | 0.87 | 110/327 | Q2 | 66.51 | 0.004 | 0.819 | 0.732 | Q2 | 100 | 100.0% | 6.7 | 13.5 | 100 | 10.9% | 2025-04-21 10:12:56 | 바로가기 |
| FISH PHYSIOLOGY AND BIOCHEMISTRY | SPRINGER | 0920-1742 | 1573-5168 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 6,353 | 2.9 | Q3 | 67.2 | 32.8 | 192/285 | 3.1 | Q3 | 2.7 | 0.5 | 0.78 | 116/315 | Q2 | 63.33 | 0.003 | 0.684 | 0.474 | Q4 | 129 | 100.0% | 8.3 | 10.1 | 129 | 5.6% | 2025-04-21 09:33:40 | 바로가기 |
| Genetic Programming and Evolvable Machines | SPRINGER | 1389-2576 | 1573-7632 | SCIE | COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE | 602 | 2.6 | Q3 | 67.2 | 32.8 | 98/145 | 2.4 | Q3 | 2.5 | 0.2 | 0.47 | 120/192 | Q3 | 37.76 | 0.000 | 0.093 | 0.483 | Q3 | 13 | 100.0% | 8.0 | 8.0 | 13 | 28.1% | 2025-04-21 09:41:01 | 바로가기 |
| Global Spine Journal | SAGE PUBLICATIONS LTD | 2192-5682 | 2192-5690 | SCIE | CLINICAL NEUROLOGY | 4,145 | 2.4 | Q3 | 67.2 | 32.8 | 143/212 | 3.0 | Q3 | 2.2 | 0.6 | 0.68 | 143/269 | Q3 | 47.03 | 0.009 | 1.946 | 0.954 | Q3 | 258 | 79.5% | 3.7 | 7.3 | 205 | 91.6% | 2025-04-21 09:39:44 | 바로가기 |
| HIV MEDICINE | WILEY | 1464-2662 | 1468-1293 | SCIE | INFECTIOUS DISEASES | 2,870 | 3.0 | Q3 | 67.2 | 32.8 | 65/96 | 3.0 | Q3 | 2.7 | 0.6 | 0.51 | 81/129 | Q3 | 37.60 | 0.005 | 0.983 | 0.998 | Q2 | 138 | 89.1% | 5.4 | 6.3 | 123 | 24.3% | 2025-04-21 10:05:01 | 바로가기 |
페이지 이동: